Conditions: Osteoporosis
Keywords: Osteoporosis Postmenopausal
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 200
Healthy volunteers: no

Brief summary:
This study will assess the effect of 26 weeks of once-weekly treatment with MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet (Fosamax Plus 70/5600) on serum levels of 25-hydroxyvitamin D \[25(OH)D\].

Detailed description:

Arms:
arm 1: Calcium supplement (elemental calcium and/or calcium carbonate) without vitamin D will also be supplied to participants

Interventions: intervention 1: MK-217A/Alendronate Sodium 70-mg/Vitamin D3 5600 IU Combination Tablet
Intervention descriptions: intervention 1: One combination tablet orally once a week

Protocol document: